Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Become Privy to Some New Product Launchs
By Staff Reporters
Visit the virtual Health 2.0 Conference Exhibit Hall of piooner blogger Matthew Holt www.Health2con.com, or click-on each individual product launch where you’ll see the introduction of brand new technologies from the following vendors:
- Remedys eRX, Matt Wiggins
- Access DNA, Lee Essner
- CarePass, Jared Crapo
- Healthline, West Shell
- LiveStrong, Tom Dean
- RelateNow, Kelly Gatzke
- Pathway Genomics, Edgar MacBean
- Trial Reach, Pablo E. Graiver
- BodiMojo, Tara Cousineau
- DNA Guide, Alice Rathjen
- Unity Medical, Michael Boerner
Disclaimer
The ME-P has no relationship with these products or vendors.
Conclusion
And so, your thoughts and comments on this Medical Executive-Post are appreciated. If you’ve ever used, seen or tried these products or services, do tell us what you think!
Sponsors Welcomed
And, credible sponsors and like-minded advertisers are always welcomed.
Link: https://healthcarefinancials.wordpress.com/2007/11/11/advertise
Share this:
Filed under: Information Technology, Marketing & Advertising | Tagged: Access DNA, BodiMojo, CarePass, DNA guide, Health 2.0 Conference, Healthline, LiveStrong, Matthew Holt, Pathway Genomics, Remedys eRX, Trail Reach, unity medical |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
The Healthline website provides some good basic information about disease states, but the amount of advertising content seems to be inappropriate.
Clicking on urinary symptoms leads to adds for various drugs. Searching for headache information leads to a page plastered with migraine medication advertisements. Personalized DNA testing is certainly cutting edge – see the Access DNA and DNA Guide sites.
However, sometimes the information is difficult to interpret, and the implications for treatment and follow-up are far from clear. A good example is the current controversy regarding early screening for those with a high genetic risk for breast cancer. According to research presented today at the annual meeting of the Radiological Society of North America, the benefits of early screening may be offset by an increase risk of cancer caused by the radiation exposure.
See http://latimesblogs.latimes.com/booster_shots/2009/12/mammography-radiation.html.
Further research is needed, but the implications of this type of genetic testing are certainly not clear. This type of genetic testing should only be done in conjunction with physician consultation.
Brian J. Knabe; MD
LikeLike
Patients Not Ready for Do-It-Yourself PHRs
Dr. Knabe, did you know that Revolution Health, started by AOL co-founder Steve Case, launched its personal health record in 2007. The product attracted much fanfare, and predictions abounded that PHRs would empower patients and change the system by giving people tools and information to actively manage their health.
http://www.ihealthbeat.org/features/2010/consumers-not-ready-for-doityourself-phrs-experts-say.aspx
Sadly last week, Revolution Health told account holders the PHR service will shut down at the end of February, 2010.
Jean
LikeLike